Siret Ratip

Prof. Siret Ratip is an experienced hematologist with a distinguished academic and clinical background. She earned her medical degree from Marmara University Faculty of Medicine and attained the rank of Associate Professor in 2000. Since 2002 she has been a valued member of the clinical team at Acıbadem Health Group, where she provides expert care and contributes to patient-focused hematology services. An active member of the professional community, Prof. Ratip holds memberships in the British Society of Haematology and the Turkish Hematology Association. Her combined academic credentials and long-standing clinical experience support a commitment to high-quality patient care, collaboration, and ongoing professional development.

Education

• 2000 Marmara University Faculty of Medicine / Associate Professor
• 1998 Marmara University Faculty of Medicine Hematology
• 1994 Marmara University Faculty of Medicine Internal Medicine
• 1987 King’s College School of Medicine School of Medicine

Experience

• 2002 Acibadem Health Group
• 1996 – 2002 Marmara University Faculty of Medicine
• 2000 Marmara University Faculty of Medicine Hospital
• 1998 Marmara University Faculty of Medicine Hospital
• 1995 – 1998 Marmara University Faculty of Medicine Hospital
• 1996 University College Hospital, London / PhD in Hemotology
• 1996 University College Hospital
• 1994 – 1995 University College Hospital, London
• 1994 – 1995 University College Hospital
• 1993 MSc Clinical Genetics, Institute of Child Health, London

Memberships

• British Society of Haematology
• Turkish Hematology Association

Publications

• Psychosocial and clinical aspects of thalassaemia intermedia and its implications for prenatal diagnosis
  Ratip S, Skuse D, Porter J, Wonke B, Yardumian A, Modell B. Archives of Disease in Childhood 1995, 72: 408-412
• Psychosocial and sociological aspects of the thalassaemias
  Ratip S, Modell B. Seminars in Haematology 1996, 33: 53-65
• Relationship between the severity of beta thalassaemia syndromes and the number of alleviating mutations
  Ratip S, Petrou M, Old JM, Wonke B, Porter J, Modell B. European Journal of Haematology 1997, 58: 14-21
• The psychosocial burden of Cooley’s anemia in affected children and their parents.
  Klein S, Sen A, Rusby J, Ratip S, Modell B, Olivieri NF. Annals of the New York Academy of Sciences 1998, 850: 512-513.
• The frequency of tuberculosis in adult allogeneic stem cell transplant recipients in Turkey.
  Biology of Blood and Marrow Transplantation 2000, 6: 370-374 8). Budak-Alpdoğan T, Tangün Y, Kalayoğlu-Beşışık S, Ratip S, Akan H, Başlar Z, Soysal T, Bayık M, Koç H.
• Double G0/G1 peak in the DNA histogram of aberrant marker positive acute leukemia patients is associated with a poor clinical outcome.
  Eksioglu-Demiralp E, Budak-Alpdogan T, Alpdogan Ö, Atalay A, Ratip S, Oz D, Bayik M, Akoglu T. Leukemia and Lymphoma 1999, 33: 567-572.
• Role of hepatocyte growth factor in the development of dendritic cells from CD34+ bone marrow cells.
  Ovali E, Ratip S, Kibaroğlu A, Tekelioğlu Y, Çetiner M, Kartı S, Aydın F, Bayık M, Akoğlu T. Haematologica 2000, 85: 457-462.
• Scleredema of Buschke associated with Waldenström’s macroglobulinaemia.
  Ratip S, Akın H, Özdemirli M, Yücelten D, Kuş S, Ekenel M, Bayık M. British Journal of Dermatology 2000, 143: 450-452.
• Efficacy of high dose methylprednisolone as a first line therapy in adult patients with idiopathic thrombocytopenic purpura.
  British Journal of Haematology 1998, 103: 1061-1063. Alpdogan Ö, Budak-Alpdogan T, Ratip S, Fıratlı-Tuğlular T, Tanrıverdi S, Kartı S, Bayık M, Akoğlu T.